Impact of a Targeted Nutritional Intervention on Glycaemic Variability and Correlation Between Glycaemic Parameters and Satiety.
Obesity in Adolescents
De qué trata este estudio
El registro no identifica actualmente este estudio como reclutando. Consulta su estado antes de planificar una evaluación.
- Tipo de estudio
- De intervención
- Fase
- No aplica
- Rango de edad
- 12 años - 18 años
- Sexo admitido
- Todos los sexos
- Voluntarios sanos
- No aceptados
- Participantes
- 20 Estimado
Estos son puntos de partida, no una decisión de elegibilidad. El equipo debe revisar todos los requisitos.
Las explicaciones y la navegación están en español. Los textos proporcionados por el registro, incluidos títulos, resúmenes y criterios, se conservan en su idioma original. Puedes pedir orientación en español a WCR.
Acerca de la investigación
Obesity affects 18% of French adults and increasingly impacts adolescents. Dietary management is challenging, particularly with eating disorders like hyperphagia. The study hypothesizes that glycaemic variability contributes to eating disorders, as blood glucose fluctuations and reactive hypoglycaemia may exacerbate compulsive eating. Currently, no data exists on the relationship between glycaemic profile and satiety in obese adolescents.
This exploratory study will establish foundation for larger research evaluating glucose sensors as therapeutic education tools in obesity management, helping patients understand diet-satiety relationships.
¿Quién podría participar?
La lista siguiente contiene el texto del patrocinador. Puede incluir condiciones, tratamientos previos, resultados de pruebas y otros requisitos. Aparecer en tu búsqueda no significa que califiques.
Inclusion Criteria:
- Adolescents who have entered puberty (Tanner S2+ or G2+)
- Aged over 12 and under 18 years
- Obese, defined by an IOTF Body Mass Index (BMI) \> 30
- Child's assent and consent from the person(s) exercising parental authority
Exclusion Criteria:
- Type 2 diabetes: HbA1c \> 6.5% or fasting plasma glucose \> 1.26 g/L
- Type 1 diabetes
- Treatment capable of altering the glycemic profile (e.g., corticosteroids)
- Intercurrent illness capable of significantly impacting eating behavior (e.g., Prader-Willi syndrome) or the postprandial glycemic profile
- Hypothalamic obesity
- Neuropsychomotor developmental disorders, intellectual disability
- History of bariatric surgery
- Pregnant, parturient, or breastfeeding women
- Persons deprived of liberty by a judicial or administrative decision
- Persons undergoing psychiatric care
- Persons admitted to a healthcare or social care facility for purposes other than the research
- Adults subject to a legal protection measure (guardianship, curatorship)
- Persons not affiliated with a social security scheme or beneficiaries of a similar scheme
- Participation in a study affecting appetite or blood glucose levels
Tratamiento, grupos y participación
El registro puede describir tratamientos y duración sin incluir un calendario completo. Pide al equipo las visitas, procedimientos, riesgos, costos y alternativas. Mantén tu atención habitual salvo que tu médico te indique un cambio.
- Asignación
- No aplica
- Enmascaramiento
- Sin enmascaramiento
Adolescents in obesity
- Adolescents who have begun puberty (Tanner S2+ or G2+)
- Aged over 12 and under 18
- Obese, defined by a Body Mass Index (BMI) IOTF \> 30
Behavioral: The primary intervention in this study is dietary counseling and education on adopting a low glycaemic index diet with sample menus provided · Device: continuous glucose monitoring (CGM) sensors
The primary intervention in this study is dietary counseling and education on adopting a low glycaemic index diet with sample menus provided BEHAVIORAL
At Day 14, participants receive dietary counseling from a department dietician focusing on a low glycaemic index diet. The intervention includes:
- Education on low glycaemic index food choices
- Provision of sample menus demonstrating low glycaemic index meal planning
- Guidance on implementing dietary changes to reduce glycaemic variability The intervention aims to modify eating behaviors by teaching participants to select foods that produce smaller, more gradual increases in blood glucose levels, potentially reducing glycaemic excursions and improving satiety.
Duration of intervention effect: 10 days (from Day 10 to Day 20) Monitoring: Participants maintain a food diary recording meal times and food types throughout the study period (Day 0 to Day 20). Continuous glucose monitoring is used to assess glycaemic response before (Day 0-10) and after (Day 10-20) the dietary intervention.
Note: The placement of two CGM sensors serves as a
continuous glucose monitoring (CGM) sensors DEVICE
Description:
Placement of continuous glucose monitoring (CGM) sensors on the back of the participant's dominant arm.
Two sensors are placed during the study:
- First sensor: Placed at Day 0, worn for 10 days (baseline period)
- Second sensor: Placed at Day 10 worn for 10 days (post-intervention period) The CGM measures interstitial fluid glucose concentrations in the range of 40 to 500 mg/dL every 5 minutes for 10 days per sensor.
Procedure: Sensors are placed according to manufacturer's recommendations. Participants receive general instructions on sensor maintenance and hygiene.
Purpose: The sensors cross the skin barrier to continuously monitor glucose levels, providing data on:
- Glycaemic variability (rate of change, coefficient of variation)
- Time in range (70-140 mg/dL)
- Time in hypoglycaemia (\<70 mg/dL)
- Time in hyperglycaemia (\>140 mg/dL)
- Average glucose levels
- Glycaemic excursions
Qué evalúan los investigadores
Estas medidas indican qué se estudia. No prueban que un tratamiento funcione.
Medidas principales
Change in Rate of Glycaemic Change (ROC) at Pre- and Post-prandial Time Points
Plazo: Day 0 to day 10 and Day 10 to day 20
Difference in the rate of change (ROC) in blood glucose levels (mg/dL/min) measured at each pre-prandial and post-prandial time point, comparing the baseline period (Day 0-10) to the post-intervention period (Day 10-20). ROC is calculated from continuous glucose monitoring data collected every 5 minutes. The change will be analyzed using paired statistical tests comparing mean ROC values before and after dietary intervention.
Medidas secundarias
Change in Glycaemic Variability Parameters
Plazo: Day 0 to Day 10 and Day 10 to Day 20
Change in glycemic variability and CGM-derived glucose metrics from baseline to post-intervention
Change in Satiety Scores
Plazo: Day 20
Change in subjective satiety from baseline (before dietary intervention) to post-intervention, assessed using a Visual Analogue Scale (VAS; 0-100 mm) and the Satiety Labeled Intensity Magnitude (SLIM) Scale.
Correlation Between Glycaemic Parameters and Satiety Scores
Plazo: Day 20
Correlation Between Glycaemic Parameters and Satiety Scores
Revisa las tablas completas y sus limitaciones en el registro oficial.
Abrir resultados oficiales ↗Centros de investigación (1)
El estado general puede diferir del estado de un centro. Confirma la disponibilidad antes de trasladarte.
1 centros
Hôpital-Femme-Mère-Enfant - Service d'endocrinologie et diabétologie pédiatriqueBron, FranceEstado desconocido
Equipo y fechas
- Patrocinador principal
- Hospices Civils de Lyon
- Inicio del estudio
- 1 dic 2026 Estimado
- Finalización primaria
- 1 jul 2028 Estimado
- Finalización del estudio
- 1 jul 2028 Estimado
- Primera publicación
- 18 ago 2026 Real
- Última actualización
- 10 nov 2026 Real
Contactos oficiales del estudio
Título oficial del estudio
Impact of a Targeted Nutritional Intervention on Glycaemic Variability
Consulta a Wellness Clinical Research
Tu mensaje va a WCR, incluso si otra organización realiza este estudio. WCR puede orientarte, pero podría no realizar este estudio, tener acceso a su equipo ni poder inscribirte.
Fuente: API v2 de ClinicalTrials.gov. Patrocinadores e investigadores envían la información. La NLM no aprueba la seguridad ni la ciencia de todos los estudios registrados. Aviso del registro.
Consultado: 12 nov 2026 · Última actualización del registro: 10 nov 2026